Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: Evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors

Endocrinology

Volumn 148, Issue 9, 2007, Pages 4509-4522

  Papageorgiou, A ^a   Denef, Carl ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA METHYLSEROTONIN; ESTRADIOL; GROWTH HORMONE; KETANSERIN; METHYSERGIDE; METITEPINE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 7 RECEPTOR; SPIPERONE; SUMATRIPTAN; TRAZODONE; TRYPTAMINE;

ADENOHYPOPHYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL AGGREGATION; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; GROWTH HORMONE RELEASE; HORMONE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULATION;

ANIMALS; CELL AGGREGATION; CELLS, CULTURED; GROWTH HORMONE; KETANSERIN; PITUITARY GLAND, ANTERIOR; RATS; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 34548066005     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0034     Document Type: Article

References (110)

1. Papageorgiou A, Denef C 2007 Estradiol induces expression of 5-hydroxytryptamine (5-HT) 4, 5-HT5 and 5-HT6 receptor mRNA in rat anterior pituitary cell aggregates and allows prolactin release via the 5-HT4 receptor. Endocrinology 148:1384-1395
2. Hardman JG, Limbird LE 2001 Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill
3. Hoyer D, Hannon JP, Martin GR 2002 Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554
4. Raap D, Van de Kar LD 1999 Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 65:1217-1235
5. Collu R, Fraschini F, Visconti P, Martini L 1972 Adrenergic and serotoninergic control of growth hormone secretion in adult male rats. Endocrinology 90:1231-1237
6. Imura H, Nakai Y, Yoshimi T 1973 Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man. J Clin Endocrinol Metab 36:204-206
7. Feldman JM, Plonk JW, Bivens CH, Lebovitz HE, Handwerger S 1975 Growth hormone and prolactin secretion in the carcinoid syndrome. Am J Med Sci 269:333-347
8. Smythe GA, Brandstater JF, Lazarus L 1975 Serotoninergic control of rat growth hormone secretion. Neuroendocrinology 17:245-257
9. Stuart M, Lazarus L, Smythe GA, Moore S, Sara V 1976 Biogenic amine control of growth hormone secretion in the fetal and neonatal rat. Neuroendocrinology 22:337-342
10. Delitala G, Devilla L, Bionda S, Franca V 1977 Suppression of human growth hormone secretion by cyproheptadine. Metabolism 26:931-936
11. Arnold MA, Fernstrom JD 1978 Serotonin receptor antagonists block a natural, short term surge in serum growth hormone levels. Endocrinology 103:1159-1163
12. Martin JB, Durand D, Gurd W, Faille G, Audet J, Brazeau P 1978 Neuropharmacological regulation of episodic growth hormone and prolactin secretion in the rat. Endocrinology 102:106-113
13. Collu R, Du RP, Tache Y 1979 Role of putative neurotransmitters in prolactin, GH and LH response to acute immobilization stress in male rats. Neuroendocrinology 28:178-186
14. Kletzky OA, Marrs RP, Nicoloff JT 1980 Effects of cyproheptadine on insulin-induced hypoglycaemia secretion of PRL, GH and cortisol. Clin Endocrinol (Oxf) 13:231-234
15. Parati EA, Zanardi P, Cocchi D, Caraceni T, Muller EE 1980 Neuroendocrine effects of quipazine in man in health state or with neurological disorders. J Neural Transm 47:273-297
16. Rabii J, Buonomo F, Scanes CG 1981 Role of serotonin in the regulation of growth hormone and prolactin secretion in the domestic fowl. J Endocrinol 90:355-358
17. Casanueva FF, Villanueva L, Penalva A, Cabezas-Cerrato J 1984 Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man. Neuroendocrinology 38:302-308
18. Hall TR, Harvey S, Chadwick A 1984 Serotonin and acetylcholine affect the release of prolactin and growth hormone from pituitary glands of domestic fowl in vitro in the presence of hypothalamic tissue. Acta Endocrinol (Copenh) 105:455-462
19. Argenio GF, Bernini GP, Sgro M, Vivaldi MS, Del Corso C, Santoni R, Franchi F 1991 Blunted growth hormone (GH) responsiveness to GH-releasing hormone in obese patients: influence of prolonged administration of the serotoninergic drug fenfluramine. Metabolism 40:724-727
20. Franceschini R, Cataldi A, Garibaldi A, Cianciosi P, Scordamaglia A, Barreca T, Rolandi E 1994 The effects of sumatriptan on pituitary secretion in man. Neuropharmacology 33:235-239
21. Herdman JR, Delva NJ, Hockney RE, Campling GM, Cowen PJ 1994 Neuroendocrine effects of sumatriptan. Psychopharmacology (Berl) 113:561-564
22. Katz LM, Nathan L, Kuhn CM, Schanberg SM 1996 Inhibition of GH in maternal separation may be mediated through altered serotonergic activity at 5-HT2A and 5-HT2C receptors. Psychoneuroendocrinology 21:219-235
23. Whale R, Bhagwagar Z, Cowen PJ 1999 Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors? Psychopharmacology 145:223-226
24. Valverde I, Penalva A, Dieguez C 2000 Influence of different serotonin receptor subtypes on growth hormone secretion. Neuroendocrinology 71:145-153
25. Pinilla L, Gonzalez LC, Tena-Sempere M, Aguilar E 2001 5-HT1 and 5-HT2 receptor agonists blunt± α-amino-3-hydroxy-5-methylisoxazole- 4-propionic acid (AMPA)-stimulated GH secretion in prepubertal male rats. Eur J Endocrinol 144:535-541
26. Lopez F, Gonzalez D, Aguilar E 1986 Serotonin stimulates GH secretion through a direct pituitary action: studies in hypophysectomized autografted animals and in perifused pituitaries. Acta Endocrinol (Copenh) 113:317-322
27. Balsa JA, Sanchez-Franco F, Pazos F, Lara JI, Lorenzo MJ, Maldonado G, Cacicedo L 1998 Direct action of serotonin on prolactin, growth hormone, corticotropin and luteinizing hormone release in cocultures of anterior and posterior pituitary lobes: autocrine and/or paracrine action of vasoactive intestinal peptide. Neuroendocrinology 68:326-333
28. Gerard C, el Mestikawy S, Lebrand C, Adrien J, Ruat M, Traiffort E, Hamon M, Martres MP 1996 Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7- dihydroxytryptamine-treated rats. Synapse 23:164-173
29. Lowry CA 2002 Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol 14:911-923
30. Johnston CA, Gibbs DM, Negro-Vilar A 1983 High concentrations of epinephrine derived from a central source and of 5-hydroxyindole-3-acetic acid in hypophysial portal plasma. Endocrinology 113:819-821
31. Zolkowska D, Rothman RB, Baumann MH 2006 Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease. J Pharmacol Exp Ther 318:604-610
32. Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L 1995 Increased plasma serotonin in primary pulmonary hypertension. Am J Med 99:249-254
33. Callebert J, Esteve JM, Herve P, Peoc'h K, Tournois C, Drouet L, Launay JM, Maroteaux L 2006 Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine-2B receptors in mice. J Pharmacol Exp Ther 317:724-731
34. Saavedra JM, Palkovits M, Kizer JS, Brownstein M, Zivin JA 1975 Distribution of biogenic amines and related enzymes in the rat pituitary gland. J Neurochem 25:257-260
35. Payette RF, Gershon MD, Nunez EA 1985 Serotonergic elements of the mammalian pituitary. Endocrinology 116:1933-1942
36. Leranth C, Palkovits M, Krieger DT 1983 Serotonin immunoreactive nerve fibers and terminals in the rat pituitary-light and electron-microscopic studies. Neuroscience 9:289-296
37. Saland LC 2001 The mammalian pituitary intermediate lobe: an update on innervation and regulation. Brain Res Bull 54:587-593
38. Westlund KN, Childs GV 1982 Localization of serotonin fibers in the rat adenohypophysis. Endocrinology 111:1761-1763
39. Ju G 1999 Evidence for direct neural regulation of the mammalian anterior pituitary. Clin Exp Pharmacol Physiol 26:757-759
40. Liu Y, Morris JF, Ju G 1996 Synaptic relationship of substance P-like-immunoreactive nerve fibers with gland cells of the anterior pituitary in the rat. Cell Tissue Res 285:227-234
41. Nunez EA, Gershon MD, Silverman AJ 1981 Uptake of 5-hydroxytryptamine by gonadotrophs of the bat's pituitary: A combined immunocytochemical radioautographic analysis. J Histochem Cytochem 29:1336-1346
42. Payette RF, Gershon MD, Nunez EA 1986 Colocalization of luteinizing hormone and serotonin in secretory granules of mammalian gonadotrophs. Anat Rec 215:51-58
43. Johns MA, Azmitia EC, Krieger DT 1982 Specific in vitro uptake of serotonin by cells in the anterior pituitary of the rat. Endocrinology 110:754-760
44. Denef C, Maertens P, Allaerts W, Mignon A, Robberecht W, Swennen L, Carmeliet P 1989 Cell-to-cell communication in peptide target cells of anterior pituitary. Methods Enzymol 168:47-71
45. Hauspie A, Seuntjens E, Vankelecom H, Denef C 2003 Stimulation of combinatorial expression of prolactin and glycoprotein hormone α-subunit genes by gonadotropin-releasing hormone and estradiol-17β in single rat pituitary cells during aggregate cell culture. Endocrinology 144:388-399
46. Houben H, Denef C 1990 Stimulation of growth hormone and prolactin release from rat pituitary cell aggregates by bombesin and ranatensin-like peptides is potentiated by estradiol, 5α-dihydrotestosterone, and dexamethasone. Endocrinology 126:2257-2266
47. Swinnen E, Boussemaere M, Denef C 2005 Stimulation and inhibition of prolactin release by prolactin-releasing peptide in rat anterior pituitary cell aggregates. J Neuroendocrinol 17:379-386
48. Langouche L, Pals K, Denef C 2002 Structure-activity relationship and signal transduction of gamma-MSH peptides in GH3 cells: further evidence for a new melanocortin receptor. Peptides 23:1077-1086
49. Houben H, Denef C 1992 Negative regulation by dexamethasone of the potentiation of neuromedin C-induced growth hormone and prolactin release by estradiol in anterior pituitary cell aggregates. Life Sci 50:775-780
50. Carmeliet P, Baes M, Denef C 1989 The glucocorticoid hormone dexamethasone reverses the growth hormone-releasing properties of the cholinomimetic carbachol. Endocrinology 124:2625-2634
51. Robberecht W, Denef C 1988 Stimulation and inhibition of pituitary growth hormone release by angiotensin II in vitro. Endocrinology 122:1496-1504
52. Bonhaus DW, Bach C, DeSouza A, Salazar FH, Matsuoka BD, Zuppan P, Chan HW, Eglen RM 1995 The pharmacology and distribution of human 5-hydroxytryptamine-2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br J Pharmacol 115:622-628
53. Bonhaus DW, Weinhardt KK, Taylor M, DeSouza A, McNeeley PM, Szczepanski K, Fontana DJ, Trinh J, Rocha CL, DawsonMW,Flippin LA, Eglen RM 1997 RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 36:621-629
54. Boess FG, Martin IL 1994 Molecular biology of 5-HT receptors. Neuropharmacology 33:275-317
55. Erlander MG, Lovenberg TW, Baron BM, de Lecea L, Danielson PE, Racke M, Slone AL, Siegel BW, Foye PE, Cannon K, Burns JE, Sutcliffe JG 1993 Two members of a distinct subfamily of 5-hydroxytryptamine receptors (5htr5) differentially expressed in rat brain. Proc Natl Acad Sci USA 90:3452-3456
56. Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, Siegel BW 1993 A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11:449-458
57. Shen Y, Monsma Jr FJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR 1993 Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268:18200-18204
58. Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL 2000 evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102:2836-2841
59. Johansson L, Sohn D, Thorberg SO, Jackson DM, Kelder D, Larsson LG, Renyi L, Ross SB, Wallsten C, Eriksson H, Hu PS, Jerning E, Mohell N, Westlind-Danielsson A 1997 The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. J Pharmacol Exp Ther 283:216-225
60. Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Gothert M, Jones BJ, Roberts C, Watson JM, Middlemiss DN 1997 SB-216641 and BRL-15572 - compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol 356:312-320
61. Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M 2004 Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors. Naunyn Schmiedebergs Arch Pharmacol 370:114-123
62. Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A 2002 Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes. J Pharmacol Exp Ther 303:791-804
63. Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW 1998 SB-224289-a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 125:202-208
64. Leysen JE, Eens A, Gommeren W, van Gompel P, Wynants J, Janssen PA 1988 Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin and tetrabenazine-like drugs. J Pharmacol Exp Ther 244:310-321
65. Hoyer D, Engel G, KalkmanHO1985 Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. Eur J Pharmacol 118:13-23
66. Hoyer D 1988 Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol Sci 9:89-94
67. Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, Thomas D, Baxter GS, Forbes IT, Ham P, Blackburn TP 1996 In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117:427-434
68. Cussac D, Newman-Tancredi A, Quentric Y, Carpentier N, Poissonnet G, Parmentier JG, Goldstein S, Millan MJ 2002 Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols. Naunyn Schmiedebergs Arch Pharmacol 365:242-252
69. Bonhaus DW, Loury DN, Jakeman LB, To Z, DeSouza A, Eglen RM, Wong EH 1993 [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels -2 binding sites in guinea pig hippocampus. J Pharmacol Exp Ther 267:961-970
70. Barnes NM, Sharp T 1999 A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152
71. Van den Wyngaert I, Gommeren W, Verhasselt P, Jurzak M, Leysen J, Luyten W, Bender E 1997 Cloning and expression of a human serotonin 5-HT4 receptor cDNA. J Neurochem 69:1810-1819
72. Bonhaus DW, Berger J, Adham N, Branchek TA, Hsu SAO, Loury DN, Leung E, Wong EHF, Clark RD, Eglen RM 1997 [3H]RS 57639, a high affinity, selective 5-HT4 receptor partial agonist, specifically labels guinea-pig striatal and rat cloned (5-HT4S and 5-HT4L) receptors. Neuropharmacology 36:671-679.
73. Ansanay H, Sebben M, Bockaert J, Dumuis A 1996 Pharmacological comparison between [3H]GR 113808 binding sites and functional 5-HT4 receptors in neurons. Eur J Pharmacol 298:165-174
74. Hirst WD, Abrahamsen B, Blaney FE, Calver AR, Aloj L, Price GW, Medhurst AD 2003 Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling. Mol Pharmacol 64:1295-1308
75. Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR 2000 A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phenol (SB-269970). J Med Chem 43:342-345
76. Wainscott DB, Lucaites VL, Kursar JD, Baez M, Nelson DL 1996 Pharmacologic characterization of the human 5-hydroxytryptamine-2B receptor: evidence for species differences. J Pharmacol Exp Ther 276:720-727
77. Egan C, Grinde E, Dupre A, Roth BL, Hake M, Teitler M, Herrick-Davis K 2000 Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors. Synapse 35:144-150
78. Herrick-Davis K, Grinde E, Gauthier C, Teitler M 1998 Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor. Ann NY Acad Sci 861:140-145
79. May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA 2003 A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole. J Med Chem 46:4188-4195
80. Lovenberg TW, Erlander MG, Baron BM, Racke M, Slone AL, Siegel BW, Craft CM, Burns JE, Danielson PE, Sutcliffe JG 1993 Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. Proc Natl Acad Sci USA 90:2184-2188
81. Wisden W, Parker EM, Mahle CD, Grisel DA, Nowak HP, Yocca FD, Felder CC, Seeburg PH, Voigt MM 1993 Cloning and characterization of the rat 5-HT5B receptor: evidence that the 5-HT5B receptor couples to a G protein in mammalian cell membranes. FEBS Lett 333:25-31
82. Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC 1993 Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 90:8547-8551
83. Peroutka SJ 1986 Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47:529-540
84. Hamblin MW, Metcalf MA, McGuffin RW, Karpells S 1992 Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity. Biochem Biophys Res Commun 184:752-759
85. Pauwels PJ, Tardif S, Palmier C, Wurch T, Colpaert FC 1997 How efficacious are 5-HT1B/D receptor ligands: an answer from gtp[γ]S binding studies with stably transfected C6-glial cell lines. Neuropharmacology 36:499-512
86. Wurch T, Palmier C, Colpaert FC, Pauwels PJ 1997 Sequence and functional analysis of cloned guinea pig and rat serotonin 5-HT1D receptors: common pharmacological features within the 5-HT1D receptor subfamily. J Neurochem 68:410-418
87. Corbett DF, Heightman TD, Moss SF, Bromidge SM, Coggon SA, Longley MJ, Roa AM, Williams JA, Thomas DR 2005 Discovery of a potent and selective 5-HT5A receptor antagonist by high-throughput chemistry. Bioorg Med Chem Lett 15:4014-4018
88. Thomas DR, Soffin EM, Roberts C, Kew JNC, de la Flor RM, Dawson LA, Fry VA, Coggon SA, Faedo S, Hayes PD 2006 SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4′-{[(2-phenylethyl)amino]methyl} -4-biphenylyl)methyl] propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain. Neuropharmacology 51:566-577
89. Roth BL, Ciaranello RD, Meltzer HY 1992 Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 260:1361-1365
90. Rees S, den Daas I, Foord S, Goodson S, Bull D, Kilpatrick G, Lee M 1994 Cloning and characterisation of the human 5-HT5A serotonin receptor. FEBS Lett 355:242-246
91. Hamblin MW, McGuffin RW, Metcalf MA, Dorsa DM, Merchant KM 1992 Distinct 5-HT1B and 5-HT1D serotonin receptors in rat: Structural and pharmacological comparison of the two cloned receptors. Mol Cell Neurosci 3:578-587
92. Kursar JD, Nelson DL, Wainscott DB, Baez M 1994 Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol Pharmacol 46:227-234
93. Kennett GA, Bright F, Trail B, Baxter GS, Blackburn TP 1996 Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety. Br J Pharmacol 117:1443-1448
94. Millan MJ, Newman-Tancredi A, Lochon S, Touzard M, Aubry S, Audinot V 2002 Specific labelling of serotonin 5-HT1B receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743: a pharmacological characterization. Pharmacol Biochem Behav 71:589-598
95. Baes M, Denef C 1987 Evidence that stimulation of growth hormone release by epinephrine and vasoactive intestinal peptide is based on cell-to-cell communication in the pituitary. Endocrinology 120:280-290
96. Denef C, Schramme C, Baes M 1984 Influence of corticosteroids on prolactin release from anterior pituitary cell aggregates cultured in serum-free medium. Differential effects on dopamine-induced inhibition, post-dopamine rebound and stimulation by TRH, vasoactive intestinal peptide (VIP), angiotensin II and isoproterenol. J Steroid Biochem 20:197-202
97. Denef C 2003 Paracrine control of lactotrope proliferation and differentiation. Trends Endocrinol Metab 14:188-195
98. Grossman CJ, Kilpatrick GJ, Bunce KT 1993 Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain. Br J Pharmacol 109:618-624
99. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP 1994 International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
100. Edagawa Y, Saito H, Abe K 2000 The serotonin 5-HT2 receptor-phospholipase C system inhibits the induction of long-term potentiation in the rat visual cortex. Eur J Neurosci 12:1391-1396
101. Marcoli M, Rosu C, Bonfanti A, Raiteri M, Maura G 2001 Inhibitory presynaptic 5-hydroxytryptamine2A receptors regulate evoked glutamate release from rat cerebellar mossy fibers. J Pharmacol Exp Ther 299:1106-1111
102. Wang SJ, Wang KY, Wang WC, Sihra TS 2006 Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors. J Neurosci Res 84:1528-1542
103. Lin SL, Setya S, Johnson-Farley NN, Cowen DS 2002 Differential coupling of 5-HT(1) receptors to G proteins of the G (i) family. Br J Pharmacol 136:1072-1078
104. Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE 1998 The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol 361:299-309
105. Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ 1999 Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells. Br J Pharmacol 128:13-20
106. Kursar JD, Nelson DL, Wainscott DB, Cohen ML, Baez M 1992 Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine-2F) from rat stomach fundus. Mol Pharmacol 42:549-557
107. Weinshank RL, Zgombick JM, Macchi MJ, Branchek TA, Hartig PR 1992 Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ. Proc Natl Acad Sci USA 89:3630-3634
108. Roth BL, Willins DL, Kristiansen K, Kroeze WK 1998 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine-2C): where structure meets function. Pharmacol Ther 79:231-257
109. Lanfumey L, Hamon M 2004 5-HT1 receptors. Curr Drug Targets CNS Neurol Disord 3:1-10
110. Carlsson L, Eriksson E, Seeman H, Jansson JO 1987 Oestradiol increases baseline growth hormone levels in the male rat: possible direct action on the pituitary. Acta Physiol Scand 129:393-399